corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8123

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Wechsler J.
Taking steps toward harmonization with Europe and Japan
Pharmaceutical Technology 1999 Mar; 23:16, 18, 20-22, 24, 26, 28, 30


Abstract:

The program of the International Conference on Harmonization (ICH) to standardize technical requirements for testing and developing new drugs and biologics in the United States, Europe, and Japan is discussed. Projects include development of a unique reimbursement system of prescription drugs as well as a common technical document (CTD) to harmonize the submission of efficacy, safety, and quality reports. The U.S. Food and Drug Administration (FDA) and European Union (EU) are also developing a mutual recognition agreement (MRA) for inspecting manufacturing facilities. ICH participation has prompted Japan to adopt new global standards for drug testing, making it easier for foreign manufacturers to develop and gain approval of new medicines for the Japanese market.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963